medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2025-9-32-36medalphabet-4382Research ArticleСтатьиПостковидный синдром с позиции ревматолога: проблемы дифференциальной диагностикиPostcovoid syndrome from the perspective of a rheumatologist: problems of differential diagnosishttps://orcid.org/0000-0002-1833-5357АроноваЕ. С.AronovaE. S.

Аронова Евгения Сергеевна - к.м.н., научный сотрудник.

Москва

Evgeniya S. Aronova - PhD Med, researcher.

Moscow

eugpozd@mail.ruhttps://orcid.org/0000-0001-7091-2054БеловБ. С.BelovB. S.

Белов Борис Сергеевич - д.м.н., зав. лабораторией.

Москва

Boris S. Belov - DM Sci (habil.), рead of Dept.

Moscow

belovbor@yandex.ruhttps://orcid.org/0000-0002-0928-3911ГридневаГ. И.GridnevaG. I.

Гриднева Галина Игоревна - к.м.н., научный сотрудник.

Москва

Galina I. Gridneva - PhD Med, researcher.

Moscow

gigridneva@mail.ruФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой», Лаборатория коморбидных инфекций и вакцинопрофилактикиРоссияV.A. Nasonova Research Institute of Rheumatology, Laboratory of Comorbid Infections and Vaccine PreventionRussian Federation20250606202509Ревматология в общей врачебной практике (1)3236Copyright © Аронова Е.С., Белов Б.С., Гриднева Г.И., 20252025Аронова Е.С., Белов Б.С., Гриднева Г.И.Aronova E.S., Belov B.S., Gridneva G.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/4382

Особенностью постковидного синдрома (ПКС) как нозологической единицы является широкий спектр клинических проявлений, что значительно затрудняет его диагностику и делает постановку диагноза возможной лишь после исключения других потенциальных причин. В статье рассматриваются симптомы, которые встречаются как при ПКС, так и при ревматических заболеваниях. Авторы делают акцент на сходстве и различиях клинических проявлений в обоих случаях, а также на методах диагностики и мониторинга, которые встречаются в литературе. Подчеркивается необходимость скрупулезного обследования пациентов с впервые возникшими симптомами для своевременного выявления ревматического заболевания.

A feature of post-covid syndrome (PCS) as a nosological unit is a wide range of clinical manifestations, which significantly complicates its diagnosis and makes diagnosis possible only after excluding other potential causes. The article discusses symptoms that occur both in PCS and in rheumatic diseases. The authors emphasize the similarities and differences in clinical manifestations in both cases, as well as the methods of diagnosis and monitoring that are found in the literature. The need for a thorough examination of patients with newly occurring symptoms for the timely detection of rheumatic disease is emphasized.

постковидный синдромартритсистемные заболевания соединительной тканиодышкасыпьперикардитpost-covid syndromearthritissystemic connective tissue diseasesshortness of breathrashpericarditisСтатья подготовлена в рамках научно-исследовательской работы ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой», № государственного задания РК 125020301268–4.The article was prepared within the framework of the research work of V.A. Nasonova Research Institute of Rheumatology, state assignment number RK 125020301268–4.ReferencesRahmati M, Udeh R, Yon DK, et al. A systematic review and meta-analysis of long-term sequelae of COVID-19 2–year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences. J Med Virol. 2023; 95: e28852. https://doi.org/10.1002/jmv.28852Rahmati M, Udeh R, Yon DK, et al. A systematic review and meta-analysis of long-term sequelae of COVID-19 2–year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences. J Med Virol. 2023; 95: e28852. https://doi.org/10.1002/jmv.28852Petersen MS, Kristiansen MF, Hanusson KD. et al. Long COVID in the Faroe Islands – a longitudinal study among non-hospitalized patients. Clin. Infect. Dis. 2021; 73: 11: e4058–e4063. https://doi.org/10.1093/cid/ciaa1792Petersen MS, Kristiansen MF, Hanusson KD. et al. Long COVID in the Faroe Islands – a longitudinal study among non-hospitalized patients. Clin. Infect. Dis. 2021; 73: 11: e4058–e4063. https://doi.org/10.1093/cid/ciaa1792Carvalho-Schneider C, Laurent E, Lemaignen A. et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021; 27 (2): 258–263. DOI: 10.1016/j.cmi.2020.09.052Carvalho-Schneider C, Laurent E, Lemaignen A. et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021; 27 (2): 258–263. DOI: 10.1016/j.cmi.2020.09.052Lopez-Leon S, Wegman-Ostrosky T, Perelman C. et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci Rep. 2021; 11: 16144. https://doi.org/10.1038/s41598-021-95565-86Lopez-Leon S, Wegman-Ostrosky T, Perelman C. et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci Rep. 2021; 11: 16144. https://doi.org/10.1038/s41598-021-95565-86Ghosn J, Piroth L, Epaulard O. et al. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin Microbiol Infect. 2021; 27 (7): 1041.e1–1041.e4. DOI: 10.1016/j.cmi.2021.03.012Ghosn J, Piroth L, Epaulard O. et al. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin Microbiol Infect. 2021; 27 (7): 1041.e1–1041.e4. DOI: 10.1016/j.cmi.2021.03.012Sulewski A, Sieroń D, Szyluk K, Dąbrowski M, Kubaszewski Ł, Lukoszek D, Christe A. Avascular Necrosis Bone Complication after Active COVID-19 Infection: Preliminary Results. Medicina (Kaunas). 2021 Nov 30; 57 (12): 1311. DOI: 10.3390/medicina57121311Sulewski A, Sieroń D, Szyluk K, Dąbrowski M, Kubaszewski Ł, Lukoszek D, Christe A. Avascular Necrosis Bone Complication after Active COVID-19 Infection: Preliminary Results. Medicina (Kaunas). 2021 Nov 30; 57 (12): 1311. DOI: 10.3390/medicina57121311Baimukhamedov C, Botabekova A, Lessova Z. et al. Osteonecrosis amid the COVID-19 pandemic. Rheumatol Int. 2023; 43 (7): 1377–1378. DOI: 10.1007/s00296-023-05332-3Baimukhamedov C, Botabekova A, Lessova Z. et al. Osteonecrosis amid the COVID-19 pandemic. Rheumatol Int. 2023; 43 (7): 1377–1378. DOI: 10.1007/s00296-023-05332-3Hassan AAA, Khalifa AA. Femoral head avascular necrosis in COVID-19 survivors: a systematic review. Rheumatol Int. 2023 Sep; 43 (9): 1583–1595. DOI: 10.1007/s00296-023-05373-8Hassan AAA, Khalifa AA. Femoral head avascular necrosis in COVID-19 survivors: a systematic review. Rheumatol Int. 2023 Sep; 43 (9): 1583–1595. DOI: 10.1007/s00296-023-05373-8Mont MA, Pivec R, Banerjee S. et al. High-Dose Corticosteroid Use and Risk of Hip Osteonecrosis: Meta-Analysis and Systematic Literature Review. J Arthroplasty. 2015 Sep; 30 (9): 1506–1512.e5. DOI: 10.1016/j.arth.2015.03.036Mont MA, Pivec R, Banerjee S. et al. High-Dose Corticosteroid Use and Risk of Hip Osteonecrosis: Meta-Analysis and Systematic Literature Review. J Arthroplasty. 2015 Sep; 30 (9): 1506–1512.e5. DOI: 10.1016/j.arth.2015.03.036Zhao R, Wang H, Wang X, Feng F. Steroid therapy and the risk of osteonecrosis in SARS patients: a dose-response meta-analysis. Osteoporos Int. 2017; 28 (3): 1027–1034. DOI: 10.1007/s00198-016-3824-zZhao R, Wang H, Wang X, Feng F. Steroid therapy and the risk of osteonecrosis in SARS patients: a dose-response meta-analysis. Osteoporos Int. 2017; 28 (3): 1027–1034. DOI: 10.1007/s00198-016-3824-zChang C, Greenspan A, Gershwin ME. The pathogenesis, diagnosis and clinical manifestations of steroid-induced osteonecrosis. J Autoimmun. 2020 Jun; 110: 102460. DOI: 10.1016/j.jaut.2020.102460Chang C, Greenspan A, Gershwin ME. The pathogenesis, diagnosis and clinical manifestations of steroid-induced osteonecrosis. J Autoimmun. 2020 Jun; 110: 102460. DOI: 10.1016/j.jaut.2020.102460Huang C, Wang Y, Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020; 395 (10223): 497–506. DOI: 10.1016/S0140–6736(20)30183-5Huang C, Wang Y, Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020; 395 (10223): 497–506. DOI: 10.1016/S0140–6736(20)30183-5Liu J, Li S, Liang B. et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020 May; 55: 102763. DOI: 10.1016/j.ebiom.2020.102763Liu J, Li S, Liang B. et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020 May; 55: 102763. DOI: 10.1016/j.ebiom.2020.102763Salvio G, Gianfelice C, Firmani F. et al. Bone metabolism in SARS-CoV-2 disease: possible osteoimmunology and gender implications. Clin Rev Bone Miner Metab. 2020; 18 (4): 51–57. DOI: 10.1007/s12018-020-09274-3Salvio G, Gianfelice C, Firmani F. et al. Bone metabolism in SARS-CoV-2 disease: possible osteoimmunology and gender implications. Clin Rev Bone Miner Metab. 2020; 18 (4): 51–57. DOI: 10.1007/s12018-020-09274-3Zhang B, Zhang S. Corticosteroid-Induced Osteonecrosis in COVID-19: A Call for Caution. J Bone Miner Res. 2020; 35 (9): 1828–1829. DOI: 10.1002/jbmr.4136Zhang B, Zhang S. Corticosteroid-Induced Osteonecrosis in COVID-19: A Call for Caution. J Bone Miner Res. 2020; 35 (9): 1828–1829. DOI: 10.1002/jbmr.4136Bejoy P, Prerona M, Yuti K. et al. COVID-19 and Its Long-Term Impact on the Cardiovascular System. Expert Rev. Cardiovasc. Ther. 2023; 21: 211–218. DOI: 10.1080/14779072.2023.2184800Bejoy P, Prerona M, Yuti K. et al. COVID-19 and Its Long-Term Impact on the Cardiovascular System. Expert Rev. Cardiovasc. Ther. 2023; 21: 211–218. DOI: 10.1080/14779072.2023.2184800Ingul CB, Grimsmo J, Mecinaj A. et al. Cardiac dysfunction and arrhythmias 3 months after hospitalization for COVID-19. J Am Heart Assoc. 2022; 11 (3): e023473. DOI: 10.1161/JAHA.121.023473Ingul CB, Grimsmo J, Mecinaj A. et al. Cardiac dysfunction and arrhythmias 3 months after hospitalization for COVID-19. J Am Heart Assoc. 2022; 11 (3): e023473. DOI: 10.1161/JAHA.121.023473Bisaccia G, Ricci F, Recce V. et al. Post-acute sequelae of COVID-19 and cardiovascular autonomic dysfunction: what do we know? J Cardiovasc Dev Dis. 2021; 8 (11): 156. DOI: 10.3390/jcdd8110156Bisaccia G, Ricci F, Recce V. et al. Post-acute sequelae of COVID-19 and cardiovascular autonomic dysfunction: what do we know? J Cardiovasc Dev Dis. 2021; 8 (11): 156. DOI: 10.3390/jcdd8110156Soewono KY, Raney KC, Sidhu MS. Pericarditis with pericardial effusion as a delayed complication of COVID-19. Proc (Bayl Univ Med Cent). 2021; 34 (5): 629–630. DOI: 10.1080/08998280.2021.1918975Soewono KY, Raney KC, Sidhu MS. Pericarditis with pericardial effusion as a delayed complication of COVID-19. Proc (Bayl Univ Med Cent). 2021; 34 (5): 629–630. DOI: 10.1080/08998280.2021.1918975Dini FL, Baldini U, Bytyçi I, et al. Acute pericarditis as a major clinical manifestation of long COVID-19 syndrome. Int J Cardiol. 2023 Mar 1; 374: 129–134. DOI: 10.1016/j.ijcard.2022.12.019Dini FL, Baldini U, Bytyçi I, et al. Acute pericarditis as a major clinical manifestation of long COVID-19 syndrome. Int J Cardiol. 2023 Mar 1; 374: 129–134. DOI: 10.1016/j.ijcard.2022.12.019Puntmann VO, Carerj ML, Wieters I. et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020; 5: 1265–1273. DOI: 10.1001/jamacardio.2020.3557Puntmann VO, Carerj ML, Wieters I. et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020; 5: 1265–1273. DOI: 10.1001/jamacardio.2020.3557Moody WE, Liu B, Mahmoud-Elsayed HM. et al. Persisting Adverse Ventricular Remodeling in COVID-19 Survivors: A Longitudinal Echocardiographic Study. J. Am. Soc. Echocardiogr. 2021; 34: 562–566. DOI: 10.1016/j.echo.2021.01.020Moody WE, Liu B, Mahmoud-Elsayed HM. et al. Persisting Adverse Ventricular Remodeling in COVID-19 Survivors: A Longitudinal Echocardiographic Study. J. Am. Soc. Echocardiogr. 2021; 34: 562–566. DOI: 10.1016/j.echo.2021.01.020Alkodaymi MS, Omrani OA, Fawzy NA. et al. Prevalence of Post-Acute COVID-19 Syndrome Symptoms at Different Follow-up Periods: A Systematic Review and Meta-Analysis. Clin. Microbiol. Infect. 2022; 28: 657–666. DOI: 10.1016/j.cmi.2022.01.014Alkodaymi MS, Omrani OA, Fawzy NA. et al. Prevalence of Post-Acute COVID-19 Syndrome Symptoms at Different Follow-up Periods: A Systematic Review and Meta-Analysis. Clin. Microbiol. Infect. 2022; 28: 657–666. DOI: 10.1016/j.cmi.2022.01.014Al-Khadra Y, Darmoch F, Moussa Pacha H. et al. P5341 Autoimmune disease association with pericar dial diseases: An analysis of the national inpatient sample. Eur Heart J. 2018; 39 (Suppl 1): ehy566.P5341. DOI: 10.1093/eurheartj/ehy566.P5341Al-Khadra Y, Darmoch F, Moussa Pacha H. et al. P5341 Autoimmune disease association with pericar dial diseases: An analysis of the national inpatient sample. Eur Heart J. 2018; 39 (Suppl 1): ehy566.P5341. DOI: 10.1093/eurheartj/ehy566.P5341Белов Б. С., Тарасова Г. М. Перикардиты в ревматологии: современные клинико-диагностические аспекты и вопросы терапии. Consilium Medicum. 2020; 22 (1): 26–30. DOI: 10.26442/20751753.2020.1.200060Belov B. S., Tarasova G. M. Pericarditis in rheumatology: modern clinical and diagnostic aspects and treatment aspects. Consilium Medicum. 2020; 22 (1): 26–30. (In Russ.). DOI: 10.26442/20751753.2020.1.200060Джузенова Б. С., Котельникова Г. П., Михайлова И. Н., Насонова В. А. Острый ревмокардит у молодых мужчин. Терапевтический архив. 1992; 4: 58–62.Dzhuzenova B. S., Kotelnikova G. P., Mikhailova I. N., Nasonova V. A. Acute rheumatic carditis in young men. Ther. archive. 1992; 4: 58–62. (In Russ.).Медынцева Л. Г. Физическая работоспособность больных ревматизмом детей на этапе диспансеризации: автореф. дис. канд. мед. наук. М., 1990.Medyntseva L. G. Physical performance of children with rheumatism at the stage of medical examination: Abstract of Cand. Sci. (Med.) dissertation. Moscow, 1990. (In Russ.).Long Q, Li J, Hu X. et al. Follow-Ups on Persistent Symptoms and Pulmonary Function Among Post-Acute COVID-19 Patients: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2021; 8: 702635. DOI: 10.3389/fmed.2021.702635Long Q, Li J, Hu X. et al. Follow-Ups on Persistent Symptoms and Pulmonary Function Among Post-Acute COVID-19 Patients: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2021; 8: 702635. DOI: 10.3389/fmed.2021.702635Cares-Marambio K, Montenegro-Jiménez Y. et al. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Chron Respir Dis. 2021; 18: 14799731211002240. DOI: 10.1177/14799731211002240Cares-Marambio K, Montenegro-Jiménez Y. et al. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Chron Respir Dis. 2021; 18: 14799731211002240. DOI: 10.1177/14799731211002240Dani M, Dirksen A, Taraborrelli P. et al. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clin med (Lond). 2021; 21 (1): e63–e67. DOI: 10.7861/clinmed.2020–0896Dani M, Dirksen A, Taraborrelli P. et al. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clin med (Lond). 2021; 21 (1): e63–e67. DOI: 10.7861/clinmed.2020–0896Duong-Quy S, Vo-Pham-Minh T, Tran-Xuan Q. et al. Post-COVID-19 Pulmonary Fibrosis: Facts-Challenges and Futures: A Narrative Review. Pulm Ther. 2023; 9 (3): 295–307. DOI: 10.1007/s41030–023–00226-y. Epub 2023 May 20.Duong-Quy S, Vo-Pham-Minh T, Tran-Xuan Q. et al. Post-COVID-19 Pulmonary Fibrosis: Facts-Challenges and Futures: A Narrative Review. Pulm Ther. 2023; 9 (3): 295–307. DOI: 10.1007/s41030–023–00226-y. Epub 2023 May 20.Guinto E, Gerayeli FV, Eddy RL. et al. Post-COVID-19 dyspnoea and pulmonary imaging: a systematic review and meta-analysis. Eur Respir Rev. 2023; 32 (169): 220253. DOI: 10.1183/16000617.0253-2022Guinto E, Gerayeli FV, Eddy RL. et al. Post-COVID-19 dyspnoea and pulmonary imaging: a systematic review and meta-analysis. Eur Respir Rev. 2023; 32 (169): 220253. DOI: 10.1183/16000617.0253-2022Wu X., Liu X., Zhou Y. et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021; 9 (7): 747–754. DOI: 10.1016/S2213-2600(21)00174-0Wu X., Liu X., Zhou Y. et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021; 9 (7): 747–754. DOI: 10.1016/S2213-2600(21)00174-0George PM, Barratt SL, Condliffe R. et al. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. 2020; 75: 1009–1016. DOI: 10.1136/thoraxjnl-2020-215314George PM, Barratt SL, Condliffe R. et al. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. 2020; 75: 1009–1016. DOI: 10.1136/thoraxjnl-2020-215314Методические рекомендации «Особенности течения long-COVID-инфекции. Терапевтические и реабилитационные мероприятия». Терапия. 2022; 1 (Приложение): 1–147. https://dx.doi.org/10.18565/therapy.2022.1suppl.1-147Guidelines «Characteristics of the course of long-COVID infection. Therapeutic and rehabilitation measures.” Therapy. 2022; 1 (Supplement): 1–147. (In Russ.). https://dx.doi.org/10.18565/therapy.2022.1suppl.1-147Recalcati S. Кожные проявления при COVID-19: первая точка зрения. J Eur Acad Dermatol Venereol. 2020; 34 (5): e212–e213. DOI: 10.1111/jdv.16387Recalcati S. Кожные проявления при COVID-19: первая точка зрения. J Eur Acad Dermatol Venereol. 2020; 34 (5): e212–e213. DOI: 10.1111/jdv.16387Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol Cell Physiol. 2022; 322 (1): C 1–C 11. DOI: 10.1152/ajpcell.00375.2021Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol Cell Physiol. 2022; 322 (1): C 1–C 11. DOI: 10.1152/ajpcell.00375.2021McGonagle D, Bridgewood C, Ramanan AV, et al. COVID-19 vasculitis and novel vasculitis mimics. Lancet Rheumatol. 2021; 3 (3): e224–e233. DOI: 10.1016/S2665-9913(20)30420-3McGonagle D, Bridgewood C, Ramanan AV, et al. COVID-19 vasculitis and novel vasculitis mimics. Lancet Rheumatol. 2021; 3 (3): e224–e233. DOI: 10.1016/S2665-9913(20)30420-3Rocha KO, Zanuncio VV, Freitas BAC, Lima LM. «COVID toes»: A meta-analysis of case and observational studies on clinical, histopathological, and laboratory findings. Pediatr Dermatol. 2021; 38 (5): 1143–1149. DOI: 10.1111/pde.14805Rocha KO, Zanuncio VV, Freitas BAC, Lima LM. «COVID toes»: A meta-analysis of case and observational studies on clinical, histopathological, and laboratory findings. Pediatr Dermatol. 2021; 38 (5): 1143–1149. DOI: 10.1111/pde.14805Mehta P, Bunker CB, Ciurtin C. et al. Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy. Lancet Infect Dis. 2021; 21 (7): 912. DOI: 10.1016/S1473-3099(21)00133-XMehta P, Bunker CB, Ciurtin C. et al. Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy. Lancet Infect Dis. 2021; 21 (7): 912. DOI: 10.1016/S1473-3099(21)00133-XChaudhary H, Mohan M, Jain A. et al. Acral Gangrene: Ugly Cousin of «COVID Toes» in Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2? Pediatr Infect Dis J. 2021; 40 (8): e312–e313. DOI: 10.1097/INF.0000000000003181Chaudhary H, Mohan M, Jain A. et al. Acral Gangrene: Ugly Cousin of «COVID Toes» in Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2? Pediatr Infect Dis J. 2021; 40 (8): e312–e313. DOI: 10.1097/INF.0000000000003181Casas G, Català A, Hernández C. et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020; 183 (1): 71–77. DOI: 10.1111/bjd.19163Casas G, Català A, Hernández C. et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020; 183 (1): 71–77. DOI: 10.1111/bjd.19163Perna A, Passiatore M, Massaro A. et al. Skin manifestations in COVID-19 patients, state of the art. A systematic review. Int J Dermatol. 2021; 60 (5): 547–553. DOI: 10.1111/ijd.15414Perna A, Passiatore M, Massaro A. et al. Skin manifestations in COVID-19 patients, state of the art. A systematic review. Int J Dermatol. 2021; 60 (5): 547–553. DOI: 10.1111/ijd.15414McMahon DE, Gallman AE, Hruza GJ. et al. Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. Lancet Infect Dis. 2021; 21 (3): 313–314. DOI: 10.1016/S1473-3099(20)30986-5McMahon DE, Gallman AE, Hruza GJ. et al. Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. Lancet Infect Dis. 2021; 21 (3): 313–314. DOI: 10.1016/S1473-3099(20)30986-5Chularojanamontri L, Tuchinda P, Rujitharanawong C. et al. New-onset and exacerbated skin diseases after COVID-19 infection: a systematic review. J Dermatol. 2022; 49 (11): e419–e421. DOI: 10.1111/1346-8138.16501Chularojanamontri L, Tuchinda P, Rujitharanawong C. et al. New-onset and exacerbated skin diseases after COVID-19 infection: a systematic review. J Dermatol. 2022; 49 (11): e419–e421. DOI: 10.1111/1346-8138.16501Shanshal M. COVID-19 related anagen effluvium. J Dermatolog Treat. 2022; 33 (2): 1114–1115. DOI: 10.1080/09546634.2020.1792400Shanshal M. COVID-19 related anagen effluvium. J Dermatolog Treat. 2022; 33 (2): 1114–1115. DOI: 10.1080/09546634.2020.1792400Aksoy H, Yıldırım UM, Ergen P, Gürel MS. COVID-19 induced telogen effluvium. Dermatol Ther. 2021; 34 (6): e15175–e15175. DOI: 10.1111/dth.15175Aksoy H, Yıldırım UM, Ergen P, Gürel MS. COVID-19 induced telogen effluvium. Dermatol Ther. 2021; 34 (6): e15175–e15175. DOI: 10.1111/dth.15175Wambier CG, Vaño-Galván S, McCoy J., et al. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: the «Gabrin sign». J Am Acad Dermatol. 2020; 83 (2): 680–682. DOI: 10.1016/j.jaad.2020.05.079Wambier CG, Vaño-Galván S, McCoy J., et al. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: the «Gabrin sign». J Am Acad Dermatol. 2020; 83 (2): 680–682. DOI: 10.1016/j.jaad.2020.05.079

The authors declare that there are no conflicts of interest present.